Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study

Sarah-Louisa Mahi1, Siamak Bahram2, Jérôme Harambat3

  • 1Service de Pédiatrie 1, CHU University Hospital Hautepierre, 1, Avenue Molière, 67098, Strasbourg, France.

Insights

Pediatric ANCA vasculitis shows increased incidence and frequent severe ENT involvement. Despite treatment changes, kidney outcomes remain poor, highlighting the need for further research into optimal therapies for children.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Nephrology

Background:

  • Pediatric ANCA-associated vasculitis (AAV) is rare with limited pediatric data.
  • Increasing incidence and evolving treatments like rituximab necessitate updated outcome analysis.
  • This study addresses the scarcity of information on AAV in children.

Purpose of the Study:

  • To characterize current pediatric AAV.
  • To analyze management strategies and outcomes.
  • To evaluate the impact of recent therapeutic trends.

Main Methods:

  • Retrospective study over 9 years.
  • Involved 46 children across 14 French centers.
  • Described clinical/laboratory features, treatments, and kidney outcomes.

Main Results:

  • P-ANCA positivity linked to higher relapse risk.
  • Frequent and severe ENT involvement noted in children compared to adults.
  • Poor kidney outcomes persisted (54.8% CKD at 1 year), with low mortality (6.5%).

Conclusions:

  • Long diagnosis times persist; P-ANCA is a significant relapse marker.
  • Treatment shifted towards rituximab, away from cyclophosphamide.
  • Kidney outcomes remain poor, underscoring the need for prospective studies on optimal therapies.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
28
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
18
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18